With a sharp rise in health research funding, the government's new Biopharma Shakti programme aims to push India beyond ...

Alongside the expansion of the national clinical trials network and strengthening of the CDSCO Central Drugs Standard Control Organisation with specialised scientific review and globally aligned ...

The Union Budget 2026 highlights India’s growing burden of diabetes, obesity and cancer. In her speech, Finance Minister ...

A Rs 10,000-crore push aims to build India’s biopharma and advanced manufacturing capabilities as disease patterns and ...

Finance Minister Nirmala Sitharaman on Sunday proposed a Rs 10,000 crore allocation over the next five years to boost India’s ...

Sitharaman also proposed setting up three new All India Institute of Ayurveda ...

Finance Minister Nirmala Sitharaman, during her ninth consecutive Budget speech, announced an outlay of ₹10,000 crore under ...

Will Budget 2026’s ₹10,000 crore Biopharma Shakti plan transform India into a global biopharma manufacturing hub? Read report ...

Union Budget 2026 announces a 10,000 crore outlay for the Biopharma Shakti Initiative to boost India's biopharmaceutical ...

Pharma stocks experienced a significant surge after Finance Minister Nirmala Sitharaman announced the Rs 10,000 crore ...

Finance Minister Nirmala Sitharaman highlighted the growing burden of diabetes, obesity and cancer in India in her 9th Budget ...